英文名称:
N-(2-(2-(2-Methoxy-4-MorpholinophenylaMino)-5-fluoropyriMidin-4-ylaMino)phenyl)MethanesulfonaMide
英文同义词:
CZC-25146;N-[2-[[5-Fluoro-2-[[2-methoxy-4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]amino]phenyl]methanesulfonamide;N-(2-(2-(2-Methoxy-4-MorpholinophenylaMino)-5-fluoropyriMidin-4-ylaMino)phenyl)MethanesulfonaMide;N-(2-((5-fluoro-2-((2-methoxy-4- morpholinophenyl)amino)pyrimidin- 4- yl)amino)phenyl)methanesulfonamide;LRRK2 Inhibitor II;LRRK2 INHIBITOR II;CZC25146;CZC 25146;CHEMBL2397014;Methanesulfonamide, N-[2-[[5-fluoro-2-[[2-methoxy-4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]amino]phenyl]-
相关类别:
Amines, Aromatics, Heterocycles, Inhibitors, Pharmaceuticals, Intermediates Fine Chemicals;API
沸点
697.4±65.0 °C(Predicted)
密度
1.436±0.06 g/cm3(Predicted)
储存条件
Inert atmosphere,2-8°C
酸度系数(pKa)
8.48±0.10(Predicted)
生物活性
CZC-25146是一种有效、选择性的LRRK2抑制剂,对human wild type LRRK2和G2019S LRRK2的IC50分别为4.76 nM和6.87 nM。
靶点
Target Value
human wild type LRRK2
(Cell-free assay) 4.76 nM
G2019S LRRK2
(Cell-free assay) 6.87 nM
human wild type LRRK2
(Cell-free assay)
4.76 nM
G2019S LRRK2
(Cell-free assay)
6.87 nM
用途
CZC-25146 is a compound that acts as an inhibitor of LRRK2, a factor in the expression of Parkinsons鈥檚 disease, and is ATP-competitive.